The news
The Oura IPO is under way. The Finnish-founded, San Francisco-based maker of the Oura Ring formally launched its initial public offering on September 21. The company said it is marketing 50 million shares at $40 to $44 each and has applied to list on the Nasdaq Global Select Market under the ticker “OURA.”
Only part of the deal raises new money for the company. Oura is selling 13.5 million shares; existing stockholders are selling the other 36.5 million and keep those proceeds. At the range, the full offering would total up to $2.2 billion, while Oura’s own slice works out to roughly $540 million to $594 million before fees. Selling shareholders also plan to give underwriters a 30-day option on 7.5 million more shares.
Goldman Sachs, Morgan Stanley, J.P. Morgan, Allen & Company and Jefferies are the lead bookrunners. Reuters put the targeted fully diluted valuation at about $15.6 billion, a figure that corresponds to the top of the price range; Renaissance Capital calculates $14.9 billion at the midpoint. Reuters also reported that Eli Lilly and Dragoneer Investment Group had indicated interest in buying up to $100 million and $300 million of stock, respectively. Indications of interest are not binding.
The financials are unusual for a consumer-hardware IPO. According to Oura’s amended S-1 registration statement, the company booked $1.21 billion in revenue in the nine months ended June 30, 2026, up 74% year over year, and reported net income of $60.8 million. Subscription revenue grew faster than hardware, though devices still made up roughly 80% of sales. The company said it expects to finish fiscal 2026 with about 5.7 million paid members, up 96%.
The filing also discloses a consumer class action challenging the accuracy of Oura’s sleep-tracking claims, according to a MarketBeat analysis syndicated on Yahoo Finance. Bloomberg reported on September 25 that the deal was about four times oversubscribed, with no change to the $40–$44 range, and was set to price on September 29.
The numbers
- Price range
- $40–$44 per share
- Shares offered
- 50M (13.5M by Oura, 36.5M by holders)
- Max offering size
- About $2.2B
- Fully diluted valuation (reported)
- Up to about $15.6B at top of range; $14.9B at midpoint
- Revenue, 9 months to June 30
- $1.21B (+74%)
Why CEOs should care
Oura is a profitable, fast-growing venture-backed company going public. How it prices and trades will shape how other late-stage consumer and health-tech companies (and their boards) think about listing versus staying private. A strong debut could pull more IPO filings forward; a weak one would reinforce the preference for secondary sales and private rounds.
For executives in health, insurance and employee benefits, the notable detail is Eli Lilly’s stated interest. It suggests that at least one major drugmaker sees continuous consumer health data as strategically valuable, which could speed partnerships between wearables makers, drugmakers and payers, along with more scrutiny of accuracy claims and data use.
What’s next
Watch where the deal prices against the range, how much of the book goes to long-term holders, and whether the 80% hardware mix weighs on the multiple once trading starts.
What “Fact-checked” means
Fact-checking means testing a story’s facts against the evidence before it is published. This story went through at least two separate checks before this version was published.
- What we checked
- Its names, figures, dates, job titles, quotes and who said what were checked against the story’s sources, including its main source where it could be opened. The headline was checked for accuracy and overstatement.
- How
- A first check reviewed the whole story. If it passed, a second, skeptical check went back to the sources to look for mistakes in the most important facts. If a check flagged the story, it was edited to fix the problems found, and a separate re-check then reviewed the whole story again.
- Who
- The checks are made by our newsroom, as steps kept separate from the writing, under rules set by our editor, Hussein Mukhtar. A story the checks still flag is held for the editor, who decides whether it is fixed, published or dropped.
- If something is wrong
- “Fact-checked” does not mean error-free. If a material error is found after publication, we correct the story and add a note saying what changed. Report an error
Companies in this story








